Neeraj Sriram, MD
Pain Medicine · Columbia, SCNPI 1467849943
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,310 of the $9,298 with a category attached, or 89.4%. 37 manufacturers reported payments, led by Medtronic at 25.4% of the total.
Across 284 payments — averaging $32.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Boston Scientific$2K
- Collegium Pharmaceutical, Inc.$753
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$584
- Abbott$296
- Nalu Medical, Inc.$275
- plus $3K from 31 others
What the payments were for
- Travel & lodging$98811%
- Food & beverage$8,31089%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 42 | $2,358 |
| Boston Scientific | 57 | $2,252 |
| Collegium Pharmaceutical, Inc. | 32 | $753 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 28 | $584 |
| Abbott | 4 | $296 |
| Nalu Medical, Inc. | 5 | $275 |
| Stryker | 1 | $248 |
| AbbVie | 18 | $238 |
| Pfizer | 13 | $235 |
| Nevro Corp. | 6 | $226 |
| IBSA Pharma Inc. | 9 | $184 |
| Azurity Pharmaceuticals, Inc. | 11 | $164 |
| Forte Bio-pharma LLC | 3 | $156 |
| Lundbeck LLC | 5 | $153 |
| Protega Pharmaceutials Inc | 8 | $135 |
| Teva Pharmaceuticals USA, Inc. | 2 | $133 |
| SPR Therapeutics, Inc | 2 | $108 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $103 |
| Stimwave Technologies Incorporated | 1 | $93 |
| Fidia Pharma USA Inc. | 2 | $74 |
| Scilex Pharmaceuticals Inc. | 5 | $67 |
| Vertex | 1 | $61 |
| Arbor Pharmaceuticals, Inc. | 4 | $60 |
| USWM, LLC | 2 | $45 |
| Vertos Medical, Inc. | 2 | $43 |
| Alkermes, Inc. | 2 | $40 |
| Spinal Simplicity, LLC | 2 | $36 |
| Indivior Inc. | 2 | $29 |
| Saluda Medical Americas, Inc. | 1 | $23 |
| Bioventus LLC | 1 | $22 |
| Valinor Pharma, LLC | 1 | $19 |
| Globus Medical | 1 | $16 |
| Virtus Pharmaceuticals LLC | 1 | $16 |
| Almatica Pharma LLC | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Avanos Medical | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$1,123
- Prolate$494
- WaveWriter Alpha Prime 16$269
- VANTA ADAPTIVESTIM$261
- OPTABLATE$248
- Omnia$148
- OCTRODE$136
- Nalu Neurostimulation System$132
- ETERNA$124
- Nalocet$124
- AJOVY$119
- Superion Indirect Decompression System$110
- GENERAL - THERAPIES$110
How this compares
$9,298 in reported general payments places this provider in the 80th percentile of 92 pain medicine providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 97 | $52,629 |
| BelbucaBuprenorphine Hcl | 47 | $31,050 |
| Buprenorphine | 129 | $28,112 |
| Oxymorphone Hcl ErOxymorphone Hcl | 18 | $12,309 |
| NucyntaTapentadol Hcl | 15 | $10,870 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 405 | $5,428 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 345 | $5,274 |
| Gabapentin ErGabapentin | 13 | $5,210 |
| Diclofenac Sodium | 64 | $2,587 |
| Morphine Sulfate ErMorphine Sulfate | 77 | $2,218 |
| Lidocaine | 30 | $2,210 |
| Gabapentin | 177 | $2,018 |
| Pregabalin | 130 | $1,960 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 21 | $1,727 |
| Hydromorphone ErHydromorphone Hcl | 12 | $1,403 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca, Nucynta | $753 | $94,549159 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 92 pain medicine providers in South Carolina.
Other pain medicine in Columbia
- Sankeerth ChallagundlaColumbia$15K
- Usama GabrColumbia$8K
- Phillip SmithGreenville$303K
- Richard KlineConway$104K
- Channing WilloughbyMurrells Inlet$82K
- Michael WarrickSumter$50K
- Daniel AtkinsonGreenville$36K
- Michael WardenFlorence$20K
- Andrew MendelsonCharleston$19K
- Kevin WalkerGreenville$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.